These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hepatitis from isoniazid and rifampin. Groopman JE; Soloff L; Tessler S N Engl J Med; 1978 Jun; 298(23):1316-7. PubMed ID: 651986 [No Abstract] [Full Text] [Related]
4. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model]. Leinweber B; Mahrt R Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192 [No Abstract] [Full Text] [Related]
5. [Detection of the effects of the rifampin-isoniazid combination on the human liver]. Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506 [No Abstract] [Full Text] [Related]
6. Present views on isoniazid and isoniazid-rifampicin hepatitis. Pessayre D Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577 [No Abstract] [Full Text] [Related]
7. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin]. Bartmann K Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784 [No Abstract] [Full Text] [Related]
8. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin]. Jean R; Bonnet H; Pages P; Dumas R; Greze J Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678 [No Abstract] [Full Text] [Related]
9. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Steele MA; Burk RF; DesPrez RM Chest; 1991 Feb; 99(2):465-71. PubMed ID: 1824929 [No Abstract] [Full Text] [Related]
10. [Fulminant hepatitis in patients with mixed connective tissue disease under antitubercular treatment with hydrazide and rifampicin]. Waitzberg VR; Gayotto LC Rev Hosp Clin Fac Med Sao Paulo; 1982 Feb; 37(1):48-51. PubMed ID: 7123064 [No Abstract] [Full Text] [Related]
11. [Clinical and pathological analysis of liver injury resulting from rifampin and isoniazid]. Xing T; Chen J; Zhang G Zhonghua Jie He He Hu Xi Za Zhi; 1997 Feb; 20(1):33-5. PubMed ID: 10072800 [TBL] [Abstract][Full Text] [Related]
12. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)]. Abeledo Mezquita G; Otero Reigada MC An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341 [TBL] [Abstract][Full Text] [Related]
13. [Liver damage from tuberculosis treatment]. Keiner F Med Klin; 1981 Jun; 76(13):376-7. PubMed ID: 7254121 [No Abstract] [Full Text] [Related]
15. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)]. Kameda K; Kawabata S; Shirai S Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075 [No Abstract] [Full Text] [Related]
16. [Icterigenic hepatitis during the treatment with combined isoniazid and rifampicin. Clinical and experimental observations]. Marche J; Hugues FC; Graisely B; Marche C Rev Tuberc Pneumol (Paris); 1971; 35(1):55-76. PubMed ID: 5559725 [No Abstract] [Full Text] [Related]
17. [Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis]. Volosevich GV Probl Tuberk; 1989; (9):72-3. PubMed ID: 2587561 [No Abstract] [Full Text] [Related]
18. [Antitubercular drug-induced liver injuries]. Guo Y; Cui D Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960 [No Abstract] [Full Text] [Related]
19. Hepatotoxicity of isoniazid and rifampin in children. Rugmini PS; Mehta S Indian Pediatr; 1984 Feb; 21(2):119-26. PubMed ID: 6469294 [No Abstract] [Full Text] [Related]
20. Increased incidence of hepatitis induced by isoniazid-rifampin combination in children. Thulasimany M J Pediatr; 1982 Jan; 100(1):174. PubMed ID: 7057311 [No Abstract] [Full Text] [Related] [Next] [New Search]